IDERA PHARMACEUTICALS INC - COM NEW (IDRA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2019

Type / Class
Equity / COM NEW
Symbol
IDRA
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2019 Q4 15,349 $28,000 +$9,304 $1.82 1
2019 Q3 10,249 $30,000 +$30,000 $2.93 1
2018 Q4 0 $0 -$4,386,000 0
2018 Q3 490,912 $4,386,000 -$57,293,617 $8.92 3
2018 Q2 45,113,579 $59,548,288 -$85,963,928 $1.32 87
2018 Q1 92,318,683 $169,812,917 +$36,240,312 $1.84 105
2017 Q4 71,508,907 $150,883,720 +$51,399,890 $2.11 105
2017 Q3 47,038,354 $104,933,191 +$1,918,560 $2.23 77
2017 Q2 46,289,190 $79,615,014 -$708,191 $1.72 75
2017 Q1 46,555,827 $114,989,251 +$13,311,778 $2.47 80
2016 Q4 48,636,323 $72,958,469 +$20,316,013 $1.50 81
2016 Q3 34,558,465 $88,463,348 +$872,867 $2.56 78
2016 Q2 34,519,029 $52,835,738 -$13,199,878 $1.53 73
2016 Q1 41,185,293 $81,541,129 -$15,468,511 $1.98 78
2015 Q4 47,233,360 $145,954,648 -$4,182,660 $3.09 85
2015 Q3 48,362,393 $162,006,382 -$39,803,408 $3.35 81
2015 Q2 60,033,600 $222,711,464 +$12,158,035 $3.71 89
2015 Q1 56,614,890 $210,033,956 +$102,979,849 $3.71 77
2014 Q4 28,964,530 $127,785,294 +$6,007,789 $4.41 63
2014 Q3 28,061,397 $64,246,433 +$7,669,177 $2.29 62
2014 Q2 24,636,548 $71,442,214 +$2,579,771 $2.90 63
2014 Q1 23,030,825 $93,921,728 -$6,781,511 $4.08 66